Hany Elsegeay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hany Elsegeay has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed E Elsaadany
Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt...
1 shared publication - Ahmed F. El-Sherbeiny
Department of Andrology, International Islamic Center for Population Studies and Research, Al-Azhar University, Cairo.
1 shared publication - Ahmed Farag Wahsh
Urology Department, Faculty of Medicine, Al- Azhar university, Asyut, Egypt
1 shared publication - Ahmed Fawzi Elsayed
Urology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt
1 shared publication - Ahmed M. Abdel Gawad
Department of Urology, Faculty of Medicine, Al-Azhar University, Damietta
1 shared publication - Ahmed Yahia Ashour
Radiology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt
1 shared publication
Latest Publications
- Open Access
- 31 October 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (6) , 2979-2992
Standalone 29-MHz micro-ultrasound for classifying clinically significant prostate cancer: a systematic review and diagnostic test accuracy meta-analysis of prospective studies
Background: Micro-ultrasound (micro-US; 29-MHz) offers real-time, high-resolution prostate imaging, but its stand-alone diagnostic accuracy remains uncertain. We synthesized prospective evidence to evaluate micro-US for classifying clinically significant prostate cancer (csPCa) using histopathology as the reference standard. Methods: We searched PubMed, Embase, Scopus, and Web of Science (inception–20 May 2025) for prospective studies assessing micro-US as an index test on a diagnostic pathway. Data were pooled using random-effects models on logit-transformed sensitivity and specificity, with an HSROC representation and model diagnostics. Subgroup and meta-regression analyses explored heterogeneity, including threshold (PRI-MUS) and spectrum effects. Clinical utility was appraised using Fagan nomograms and a likelihood-ratio scatter. Small-study effects were evaluated with Deeks’ test. Results: Five prospective studies met criteria. Pooled sensitivity was 0.84 (95% CI 0.65–0.94) and pooled specificity was 0.41 (95% CI 0.25–0.59), indicating moderate discrimination on HSROC. Secondary metrics were concordant (PLR 1.45, 95% CI 1.17–1.80; NLR 0.37, 95% CI 0.23–0.61; DOR 3.95, 95% CI 2.48–6.30). On a 25% pre-test probability, the Fagan nomogram showed modest shifts (~ 33% after a positive test; ~11% after a negative), supporting a triage/rule-out role. Heterogeneity was substantial and strongly influenced by threshold and clinical spectrum differences; subgroup and meta-regression suggested that spectrum-related factors were associated with lower specificity, whereas no covariate robustly altered sensitivity (exploratory given small k). Model checks were acceptable, and Deeks’ test showed no evidence of small-study effects ( p ≈ 0.70). Conclusion: As a stand-alone index test for csPCa classification, micro-US demonstrates high sensitivity but low specificity, yielding modest impact on post-test probability. These findings support micro-US as a complementary/triage (rule-out) adjunct, particularly when mpMRI is unavailable, contraindicated, or delayed, while highlighting the need for standardized PRI-MUS thresholds, reader training, and larger multicenter studies to refine specificity and clarify integration with MRI-based pathways.
- 31 October 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (6) , 2979-2992
Open AccessStandalone 29-MHz micro-ultrasound for classifying clinically significant prostate cancer: a systematic review and diagnostic test accuracy meta-analysis of prospective studies
Background: Micro-ultrasound (micro-US; 29-MHz) offers real-time, high-resolution prostate imaging, but its stand-alone diagnostic accuracy remains uncertain. We synthesized prospective evidence to evaluate micro-US for classifying clinically significant prostate cancer (csPCa) using histopathology as the reference standard. Methods: We searched PubMed, Embase, Scopus, and Web of Science (inception–20 May 2025) for prospective studies assessing micro-US as an index test on a diagnostic pathway. Data were pooled using random-effects models on logit-transformed sensitivity and specificity, with an HSROC representation and model diagnostics. Subgroup and meta-regression analyses explored heterogeneity, including threshold (PRI-MUS) and spectrum effects. Clinical utility was appraised using Fagan nomograms and a likelihood-ratio scatter. Small-study effects were evaluated with Deeks’ test. Results: Five prospective studies met criteria. Pooled sensitivity was 0.84 (95% CI 0.65–0.94) and pooled specificity was 0.41 (95% CI 0.25–0.59), indicating moderate discrimination on HSROC. Secondary metrics were concordant (PLR 1.45, 95% CI 1.17–1.80; NLR 0.37, 95% CI 0.23–0.61; DOR 3.95, 95% CI 2.48–6.30). On a 25% pre-test probability, the Fagan nomogram showed modest shifts (~ 33% after a positive test; ~11% after a negative), supporting a triage/rule-out role. Heterogeneity was substantial and strongly influenced by threshold and clinical spectrum differences; subgroup and meta-regression suggested that spectrum-related factors were associated with lower specificity, whereas no covariate robustly altered sensitivity (exploratory given small k). Model checks were acceptable, and Deeks’ test showed no evidence of small-study effects ( p ≈ 0.70). Conclusion: As a stand-alone index test for csPCa classification, micro-US demonstrates high sensitivity but low specificity, yielding modest impact on post-test probability. These findings support micro-US as a complementary/triage (rule-out) adjunct, particularly when mpMRI is unavailable, contraindicated, or delayed, while highlighting the need for standardized PRI-MUS thresholds, reader training, and larger multicenter studies to refine specificity and clarify integration with MRI-based pathways.
- Open Access
- 30 June 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (2) , 13938
The changes of semen parameters of patients with clinical versus subclinical varicocele managed by laparoscopic varicocelectomy: observational study
Objectives: To assess the effectiveness of laparoscopic varicocelectomy in patients with clinical versus subclinical varicocele concerning preoperative and postoperative seminal parameters. Patients and methods: Between February 2021 and August 2024, a total of 162 patients diagnosed with varicocele (72 with subclinical and 90 with clinical presentation) seeking infertility advice (primary or secondary) at the author's institution underwent laparoscopic varicocelectomy and were enrolled in the study. All patients underwent history taking, clinical examination, semen analysis, and scrotal colour Doppler ultrasonography. Patients with recurrent varicocele, azoospermia, or infertility due to causes other than varicocele were excluded from the study. Semen analysis was conducted for all patients before laparoscopic varicocelectomy and 3 to 6 months after varicocelectomy. Results: Significant improvements in seminal parameters were observed in patients with clinical varicocele (p < 0.05). Bilateral and right-sided varicoceles were more prevalent in patients with subclinical varicocele. Additionally, the incidence of secondary infertility was higher in patients with subclinical varicocele compared to those with clinical varicocele (p<0.05). Conclusions: Our study indicates favourable outcomes of laparoscopic varicocelectomy in patients with clinical varicocele. Regarding the effects of varicocelectomy in patients with subclinical varicocele, we recommend avoiding varicocelectomy in subclinical group of patients unless no identifiable causes of semen abnormality.
- 30 June 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (2) , 13938
Open AccessThe changes of semen parameters of patients with clinical versus subclinical varicocele managed by laparoscopic varicocelectomy: observational study
Objectives: To assess the effectiveness of laparoscopic varicocelectomy in patients with clinical versus subclinical varicocele concerning preoperative and postoperative seminal parameters. Patients and methods: Between February 2021 and August 2024, a total of 162 patients diagnosed with varicocele (72 with subclinical and 90 with clinical presentation) seeking infertility advice (primary or secondary) at the author's institution underwent laparoscopic varicocelectomy and were enrolled in the study. All patients underwent history taking, clinical examination, semen analysis, and scrotal colour Doppler ultrasonography. Patients with recurrent varicocele, azoospermia, or infertility due to causes other than varicocele were excluded from the study. Semen analysis was conducted for all patients before laparoscopic varicocelectomy and 3 to 6 months after varicocelectomy. Results: Significant improvements in seminal parameters were observed in patients with clinical varicocele (p < 0.05). Bilateral and right-sided varicoceles were more prevalent in patients with subclinical varicocele. Additionally, the incidence of secondary infertility was higher in patients with subclinical varicocele compared to those with clinical varicocele (p<0.05). Conclusions: Our study indicates favourable outcomes of laparoscopic varicocelectomy in patients with clinical varicocele. Regarding the effects of varicocelectomy in patients with subclinical varicocele, we recommend avoiding varicocelectomy in subclinical group of patients unless no identifiable causes of semen abnormality.